Beijing Ql Biopharmaceutical Co.,ltd
Clinical trials sponsored by Beijing Ql Biopharmaceutical Co.,ltd, explained in plain language.
-
New drug trial aims to help adults shed pounds and keep them off
Disease control Not yet recruitingThis study is testing whether an investigational drug called Zovaglutide can help adults with overweight or obesity lose weight and keep it off. About 744 participants will receive either Zovaglutide or a placebo (a dummy treatment) for 52 weeks to see how much weight they lose a…
Phase: PHASE3 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New pill aims to help shed pounds in overweight adults
Disease control Not yet recruitingThis study is testing whether a new tablet called ZT006 helps people with overweight or obesity lose weight. About 180 participants will take either ZT006 or a placebo (a dummy pill) for 28 weeks, while also following a diet and exercise plan. The main goal is to see how much bod…
Phase: PHASE2 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
First human test: can new weight drug work safely for people with kidney problems?
Knowledge-focused Not yet recruitingThis is an early safety study for a new injectable drug called ZT002, being developed for overweight and obesity. It aims to understand how the drug is processed by the body in 40 people with different levels of kidney function, compared to people with normal kidneys. The main go…
Phase: PHASE1 • Sponsor: Beijing QL Biopharmaceutical Co.,Ltd • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:26 UTC